中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Menu
Issue 4
Apr.  2011
Turn off MathJax
Article Contents
Abstract
References
Article Navigation >  Journal of Clinical Hepatology  > 2011  >  27(4): 420-423

Relationship between adiponectin and β-cell function and insulin resistance in female patients with nonalcoholic fatty liver disease

Research funding:

 

  • Published Date: 2011-04-20
    Abstract
  • Objective To investigate adiponectin level in female patients with nonalcoholic fatty liver disease (NAFLD) , and to explore the relationship between adiponectin and ?-cell function and insulin resistance.Methods The investigation used case control study.Nine patients with nonalcoholic fatty liver disease (NAFLD) and seven control subjects (C) were analyzed for ?-cell function and insulin resistance by hyperglycemic clamp.Serum adiponectin was assayed by ELISA.Subcutaneous adipose areas (SA) , visceral adipose areas (VA) , liver inphase (IP) and outphase (OP) were measured by MRI.Results The result showed the levels of fasting insulin (FINS) , first phase insulin release (1Ph) , glucose disposal rates (M) , insulin sensitivity index (ISI) , and adiponectin were significantly lower in NAFLD than those in C group (P<0.05) .Spearman correlation analysis showed adiponectin was positively associated with M (r=0.526, P=0.036) , ISI (r=0.682, P=0.005) , 1Ph (r=0.676, P=0.003) , liver OP (r=0.682, P=0.004) and OP/IP (r=0.594, P=0.015) .Conclusion The result suggested that adiponectin level was decreased in female patients with NAFLD.Hypoadiponectinemia may be associated with insulin resistance and early beta-cell dysfunction in NAFLD.

     

    • FullText(HTML)
    • References(10)
  • [1]刘军, 高鑫, 陈影, 等.非酒精性脂性肝脏疾病与胰岛素抵抗抵抗的关系[J].中华糖尿病杂志, 2004, 12 (2) :114-119.
    [2]范小芬, 邓银泉.非酒精性脂肪肝患者的胰岛素抵抗状态[J].浙江医学, 2002, 24 (5) :267-269.
    [3]Pagano C, Soardo G, Esposito W, et al.Plasma adiponectinis decreased in nonalcoholic fatty liver disease[J].EurlEndocrinol, 2005, 152 (1) :113-118.
    [4]陈卫星, 虞朝辉, 厉有名, 等.非酒精性脂肪肝与胰岛素抵抗及糖代谢异常的关系[J].中华肝脏病杂志, 2000, 8 (2) :76-77.
    [5]Marchesini G, Brizi M, Morselli Labate AM, et al.Associationof nonalcoholic fatty liver disease with insulin resistance[J].Am J Med, 1999, 107 (5) :450-455.
    [6]朱敏, 贾伟平, 包玉倩, 等.高葡萄糖钳夹技术的建立[J].中华糖尿病杂志, 2004, 12 (1) :23-27.
    [7]Seppala-Lindroos A, Vehkavaara S, Hakkinen AM, et al.Fat accumulation in the liver is associated with defects ininsulin suppression of glucose production and serum freefatty acids independent of obesity in normal men[J].J ClinEndocrinol Metab, 2002, 87 (7) :3028-3032.
    [8]Marchesini G, Bugianesi E, Forlani G, et al.Nonalcoholicfatty liver, steatohepatitis, and the metabolic syndrome[J].Hepatology, 2003, 37 (4) :917-923.
    [9]刘军, 查英, 许火根, 等.血清睾酮与脂联素、颈动脉内膜-中层厚度之间的关系探讨[J].临床内科杂志, 2005, 22 (6) :411-412.
    [10]Bugianesi E, Pagotto U, Manini R, et al.Plasma adiponectinin nonalcoholic fatty liver is related to hepatic insulinresistance and hepatic fat content, not to liver diseaseseverity[J].J Clin Endocrinol Metab, 2005, 90 (6) :3498-3504.
    • Relative Articles

  • Relative Articles

    [1]XU Zhen, LIU ShouSheng, TAN Jie, SUN BaoKai, DU ShuiXian, XIN YongNing, XUAN ShiYing. Expression and significance of leptin and adiponectin in serum of patients with nonalcoholic fatty liver disease and coronary heart disease[J]. Journal of Clinical Hepatology, 2020, 36(11): 2478-2483. doi: 10.3969/j.issn.1001-5256.2020.11.016
    [2]Wang CuiHua, Yue Yan. Research progress in relationship of leptin and adiponectin with non-alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2015, 31(8): 1351-1354. doi: 10.3969/j.issn.1001-5256.2015.08.045
    [3]Kong Yin, Zhang LingYi. The role of leptin and adiponectin in non-alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2011, 27(4): 441-443.
    [4]Zhao ZhengBin, Li JunFeng, Huang ShuangSheng, Zhang LiTing, Chen Hong. The advances of profibrogenic research of leptin and its signaling pathways in hepatic fibrosis[J]. Journal of Clinical Hepatology, 2011, 27(10): 1106-1108.
    [6]Wang ChunPing, Zhang Ming. Evaluation of leptin receptor Gln223Arg polymorphism in patients with non-alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2008, 24(3): 194-196.
    [7]Li Mei, Liang YingYin, Lin HongZheng, Xu Ya, Chen SongLin, Liu SiChun. Clinical analysis of 32 cases with alcoholic liver disease and alcohol with drawal syndrome[J]. Journal of Clinical Hepatology, 2007, 23(1): 38-39.
    [8]Li YuQin, Po YunFeng, Chen ZhaoJie, Ding BaiJing, Tang TongYu, Wang Dan, Gao YanHang, Jin JingLan. Relationship between the levels of serum leptin and insulin resistance in patients with fatty liver[J]. Journal of Clinical Hepatology, 2007, 23(5): 360-361.
    [9]Li RuiYan, Xiong JinHu. Evaluation of the clinical value of the concentration of leptin in viral hepatitis[J]. Journal of Clinical Hepatology, 2007, 23(2): 96-97.
    [11]Liu FengHai, Sun LinYu, Tan HaiYan, Liu XiaoLi. The clinical significance of serum leptin levels in patients with nonalcoholic fatty liver[J]. Journal of Clinical Hepatology, 2006, 22(1): 41-42.
    [12]Zheng JiMin, Jiang HuiQing, Lu: XiaoPing, Zhang XiangMei. Measurement of ghrelin leptin levels in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2006, 22(3): 195-196.
    [13]Lu ZhenYa, Wang QunYan, Rao WeiQiang, Cai WeiMin. Relationship between leptin resistance and nonalcoholic fatty liver in male patients.[J]. Journal of Clinical Hepatology, 2006, 22(1): 39-41.
    [14]Wang RuiKe, Liu XiuZhen, Zhang GuYun, Li Hong, Sun ZhaoCui, Zhang JinAn. Monitoring the change of interleukin-6 in the alcoholic liver disease and its clinical significance[J]. Journal of Clinical Hepatology, 2005, 21(2): 100-101.
    [15]Wang HaiQin, Li JuanJuan. Therapeutic effect of GSH on the treatment of alcoholic liver diseases.[J]. Journal of Clinical Hepatology, 2004, 20(6): 355-356.
    [16]Li ChuanFeng, Huang YongCan, Qiu Xiang, Po YunFeng. Clinical analysis of 146 cases of alcoholic liver diseases.[J]. Journal of Clinical Hepatology, 2004, 20(3): 157-158.
    [17]Lu ZhenYa, Wang QunYan, Rao WeiQiang, Cai WeiMin, Liu RongHua. The relationship between serum leptin levels and the levels of fibrosis marks in patients with hepatitis B.[J]. Journal of Clinical Hepatology, 2004, 20(2): 85-86.
    • Supplements(0)
    • Cited By
  • 加载中
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 6.4 %FULLTEXT: 6.4 %META: 89.6 %META: 89.6 %PDF: 4.0 %PDF: 4.0 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 5.0 %其他: 5.0 %其他: 0.5 %其他: 0.5 %United States: 0.2 %United States: 0.2 %三亚: 0.2 %三亚: 0.2 %上海: 2.1 %上海: 2.1 %东京: 0.2 %东京: 0.2 %东莞: 0.2 %东莞: 0.2 %北京: 10.4 %北京: 10.4 %南京: 1.2 %南京: 1.2 %南宁: 0.2 %南宁: 0.2 %吉林: 0.2 %吉林: 0.2 %哥伦布: 0.2 %哥伦布: 0.2 %天津: 0.5 %天津: 0.5 %广州: 1.2 %广州: 1.2 %张家口: 2.6 %张家口: 2.6 %悉尼: 0.2 %悉尼: 0.2 %成都: 0.2 %成都: 0.2 %无锡: 0.5 %无锡: 0.5 %武汉: 0.9 %武汉: 0.9 %沈阳: 0.5 %沈阳: 0.5 %泉州: 0.2 %泉州: 0.2 %济南: 0.7 %济南: 0.7 %漯河: 0.2 %漯河: 0.2 %石家庄: 0.5 %石家庄: 0.5 %绍兴: 0.2 %绍兴: 0.2 %芒廷维尤: 34.2 %芒廷维尤: 34.2 %芝加哥: 0.7 %芝加哥: 0.7 %苏州: 0.2 %苏州: 0.2 %莫斯科: 0.9 %莫斯科: 0.9 %西宁: 30.4 %西宁: 30.4 %西安: 0.5 %西安: 0.5 %长春: 1.7 %长春: 1.7 %长沙: 1.4 %长沙: 1.4 %青岛: 0.7 %青岛: 0.7 %其他其他United States三亚上海东京东莞北京南京南宁吉林哥伦布天津广州张家口悉尼成都无锡武汉沈阳泉州济南漯河石家庄绍兴芒廷维尤芝加哥苏州莫斯科西宁西安长春长沙青岛

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (2333) PDF downloads(764) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[2530]YesterdayPV[4969]TodayIP[896]TodayPV[1441]Online[121]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return